Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Merck
Mallinckrodt
Harvard Business School
AstraZeneca

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Patent: 8,821,836

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,821,836
Title:SPARC binding peptides and uses thereof
Abstract: The invention provides SPARC and Albumin binding peptides for the targeting of disease sites, such as tumors, with therapeutic and diagnostic agents. In particular, compositions comprising SPARC binding peptide-Antibody Fc domain fusion proteins and methods of their use are disclosed.
Inventor(s): Trieu; Vuong (Agoura Hills, CA)
Assignee: Abraxis BioScience, LLC (Los Angeles, CA)
Application Number:13/896,973
Patent Claims:see list of patent claims

Details for Patent 8,821,836

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Abraxis BioScience, LLC (Los Angeles, CA) 2028-12-05 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Abraxis BioScience, LLC (Los Angeles, CA) 2028-12-05 RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Start Trial Abraxis BioScience, LLC (Los Angeles, CA) 2028-12-05 RX Orphan search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Abraxis BioScience, LLC (Los Angeles, CA) 2028-12-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,821,836

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Moodys
Harvard Business School
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.